Ulcertaive colitis and Crohn’s disease treatments vary widely in efficacy, which can call for changes in treatment plans, according to a Medscape report. Here are three things to know about the cost ...

https://www.tipranks.com/news/the-fly/evofem-says-fda-orange-book-lists-patent-for-solosec-treatment-thefly The U.K.’s Medicines and Healthcare products Regulatory ...

International researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically with ulcerative colitis (UC) and Crohn’s disease (CD).

Please provide your email address to receive an email when new articles are posted on . Treatment options for patients with inflammatory bowel disease — particularly in the anti-interleukin-23 space — ...

Specific protein signatures could predict a future diagnosis of Crohn disease and ulcerative colitis, potentially enabling earlier intervention and improving patient outcomes. Researchers identified ...